Literature DB >> 11005272

Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice.

L Bartolone1, G Smedile, V Arcoraci, F Trimarchi, S Benvenga.   

Abstract

A 19-year-old nulliparous hirsute woman was evaluated for the very high serum levels of testosterone (T) and estradiol (E2) measured in an outside laboratory. Menarche had occurred at 11 years and was followed by regular menses. We confirmed the high levels of T (9-16 ng/ml, nv 0.2-0.8) and E2 (>1,000 pg/ml, nv 30-120). LH and FSH were consistently high (73-118 mU/l and 18-29 mU/l, respectively; LH/FSH ratio=4.1-4.7) and responsive to iv GnRH (LH baseline=118 mU/I, 30 min=290; FSH baseline=25 mU/l, 30 min=46). The unstimulated values contrasted with those (LH=12, FSH=8 mU/I) measured in the outside laboratory, suggesting antigenically anomalous gonadotropins. 17-OH-progesterone was normal (0.5 ng/ml). After 1 mg dexamethasone, serum cortisol was normally suppressed (24-->0.4 microg/dl), T declined minimally (9-->8.6 ng/ml) and E2 remained high (>1,000 pg/ml). An exploratory laparotomy was performed, and two enlarged ovaries with multiple cysts as in a typical polycystic ovarian syndrome (PCOS) were seen. Before the wedge resection of the ovaries, hormones were assayed in the ovary veins (right ovary: T=30 ng/ml, Pg=17 ng/ml, E2=>5,000 pg/ml; left: T=14 ng/ml, Pg=14 ng/ml, E2=>5,000 pg/ml). Histologically, the follicle cysts showed luteinization of the theca interna; there was no evidence for ovary tumor in either ovary. After 21 days of 35 microg ethynyl-E2+2 mg cyproterone acetate (CA), E2=3,000 pg/ml, T=1.4 ng/ml, LH=10.5 mU/l and FSH=4.1 mU/I. After three cycles of the said therapy (but with 50 mg CA in the first 10 days of each cycle), E2 was 1,600 pg/ml, T 1.7 ng/ml, LH 7.1 and FSH 4.6 mU/I. Based on similarities with the phenotype of the alpha estrogen receptor knockout female mice (alphaERKO), one possible explanation for the puzzling clinical and biochemical picture of our patient is resistance of (alphaER to estrogens. This is the first case of PCOS with extremely high E2 and T. Thus, the differential diagnosis of high levels of E2 +/- T should include PCOS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005272     DOI: 10.1007/bf03343757

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  [Effects of several estrogenic compounds on serum corticosteroid-binding globulin (CBG) and the estrogen thresholds for increasing CBG (author's transl)].

Authors:  S Kawagoe; M Hiroi
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1978-05-20

2.  Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group.

Authors:  C Nilsson; K Pettersson; R P Millar; K A Coerver; M M Matzuk; I T Huhtaniemi
Journal:  Fertil Steril       Date:  1997-06       Impact factor: 7.329

3.  Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.

Authors:  J F Couse; D O Bunch; J Lindzey; D W Schomberg; K S Korach
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

4.  Occurrence and biological properties of a common genetic variant of luteinizing hormone.

Authors:  A M Haavisto; K Pettersson; M Bergendahl; A Virkamäki; I Huhtaniemi
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

5.  Excessive estradiol secretion in polycystic ovarian disease.

Authors:  F Benjamin; A W Toles; V L Seltzer; S Deutsch
Journal:  Am J Obstet Gynecol       Date:  1993-11       Impact factor: 8.661

6.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

Authors:  E P Smith; J Boyd; G R Frank; H Takahashi; R M Cohen; B Specker; T C Williams; D B Lubahn; K S Korach
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

7.  Effect of estradiol on DHEAS production in the human adrenocortical cell line, H295R.

Authors:  J S Gell; J Oh; W E Rainey; B R Carr
Journal:  J Soc Gynecol Investig       Date:  1998 May-Jun

Review 8.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

9.  Stimulatory effect of estrogen on prolactin secretion from primate pituitary cells cultured on extracellular matrix and in serum-free medium.

Authors:  C L Bethea
Journal:  Endocrinology       Date:  1984-08       Impact factor: 4.736

10.  Differential expression of estrogen receptor-beta and estrogen receptor-alpha in the rat ovary.

Authors:  M Sar; F Welsch
Journal:  Endocrinology       Date:  1999-02       Impact factor: 4.736

View more
  1 in total

Review 1.  Towards improved genetic diagnosis of human differences of sex development.

Authors:  Emmanuèle C Délot; Eric Vilain
Journal:  Nat Rev Genet       Date:  2021-06-03       Impact factor: 53.242

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.